In This Section
SUDI Medical Cannabis Education Faculty, Guest Lecturers and Planning Committee Members
Christine Roussel, PharmD, BCOP; Certification Course Director, planning committee, presenter
Dr Christine Roussel is a Board-certified Oncology Pharmacist with a Bachelors. in Toxicology and Doctorate in Pharmacy from University of the Sciences. Her passions include occupational exposure to hazardous drugs, compounding and legislative topics, such as Medical Cannabis.
She is Assistant Director of Pharmacy at Doylestown Hospital, an adjunct professor at USciences, and co-founder of the American Society of Cannabis Pharmacists.
Dr. Roussel is a facilitator and content author for Medisca (LP3 Network), for whom she provides over 100 hours of CE on Sterile, Non-Sterile and Hazardous Drug compounding throughout the US and Canada, as well as serves as a pharmacy consultant specializing in compliance and compounding facility design.
Joseph Morgan, MD, AACM; Certification course planning committee, presenter
Graduated from Penn State and Drexel Med (Hahnemann). He is Pennsylvania's first Diplomate of the American Academy of Cannabinoid Medicine based on clinical Cannabis training in California and Israel and original research culminating in a US patent pending. That patent, "Use of cannabinoids and terpenes for the treatment of organophosphate and carbamate toxicity" is licensed to Intiva Biopharma for developing FDA-approvable drugs to treat chemical war nerve gas toxicities and other indications. Currently Medical Monitor at Onconova Therapeutics in Newtown, PA (MDS/AML investigational therapies), Dr Morgan also consulted for a Pennsylvania Cannabis Applicant but has no current relationships with any Pennsylvania or other Cannabis companies. He specializes in historical medical uses of Cannabis, regulatory history, comparative drug efficacies and toxicities, rationale pharmacotherapy, and uses of FDA-approved dronabinol. His medical practice was in Drug & Alcohol Rehab including at the Department of Medicine at Eagleville Hospital prior to a drug safety and clinical research career in pharma and biotech.
As a Dean’s Professor for University of the Sciences in Philadelphia and Guest Scientist at Wm Patterson U in Wayne, NJ (Biology/cannabinoid research lab), Dr. Morgan educates healthcare professionals and students on the basic science and clinical considerations of medical cannabis and other cannabinoids, as approved by Pennsylvania’s Department of Health (Humans) and federal regulatory agencies (Humans and animals).
David Johnson, Pharm.D., BCPS; Certification Course planning committee, presenter
Dr. David Johnson is the residency program director for the PGY-2 Solid Organ Transplant pharmacy residency at University of Pennsylvania. He received his BA degree from the University of Pennsylvania, College of Arts and Sciences and obtained his Pharm.D. degree from University of Michigan, College of Pharmacy. After graduating from U of M he completed his PGY1 & PGY2-Solid Organ Transplantation at the UPMC & University of Pittsburgh School of Pharmacy. Dr. Johnson has maintained a clinical practice as in abdominal transplant pharmacotherapy since completing his training, and is also a member of the UPenn Vascular Composite - Hand and Limb Transplant Program.
Dr. Johnson’s interests include professional mentoring, medical cannabis in transplantation - particularly drug interactions with immunosuppression and appropriate management of medical cannabis in organ transplant recipients. His publications include papers in Transplant Infectious Disease, Liver Transplantation, and the American Journal of Kidney Disease. Dr. Johnson institutional appointments include Adjunct Assistant Clinical Professor at Temple University School of Pharmacy.
Additional Medical Cannabis faculty and Presenters
Melani Bersten, PharmD, RPh; Advanced Cannabis: Dosing & Dispensing course director, presenter
Dr. Melani Bersten, PharmD graduated from Philadelphia College of Pharmacy and returned to Minnesota as a clinical cannabis pharmacist.
Dr. Bersten co-founded the American Society of Cannabis Pharmacists (ASCPh) to unify the pharmacy profession on the subject of cannabis in support of American public health.
Dr. Bersten has been invited to speak on medical cannabis across the country and loves hearing how medical cannabis has helped the people she meets along the way.
Maria Foy, PharmD, BCPS, CPE is a clinical pharmacy specialist in Palliative Care at Abington Hospital Jefferson Health, a 660 bed community teaching hospital outside of Philadelphia. Maria graduated from Temple with a BS in Pharmacy and holds a PharmD from USciences.
A Certified Pain Educator (CPE) and board certified in pharmacotherapy (BCPS), Maria received the Joe E. Smith Award from the PA Society of Health System Pharmacy in 2017, the states’ recognition for excellence in clinical practice. She was recognized with a Patient Safety Award at Abington Jefferson Health for her work to develop safe opioid prescribing practices.
Adam C. Lake, MD, FAAFP, AAHIVS, FACMQ practices at Penn LGHealth in Lancaster, where he is on the faculty of the family medicine residency program. His areas of expertise include addiction medicine, HIV/AIDS, Hep-C, and lesbian, gay, bisexual, and transgender health.
Dr Lake studied linguistics & biochemistry at Grinnell College, medicine at Temple University, permaculture & traditional medicine in Latin America, & completed a fellowship in population health. Dr Lake is a registered physician in the PA Medical Marijuana program, and lectures locally and regionally on treatment of opioid use disorder and medical marijuana.
Medical Cannabis Education: Planning Committee Members
- Andrew Peterson, PharmD, PhD, Executive Director, SUDI
- Gail Groves Scott, Manager, SUDI
- Vince Paul, RPh, Manager of Continuing Education, Alpha Zeta Omega National Pharmaceutical Fraternity, Philadelphia Alumni Chapter (AZO)
The following speakers, faculty, and/or planning committee members disclose as follows, if they, or a primary relative have a financial interest/arrangement or affiliation with one or more organizations in the last 12 months that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.
Melani Bersten, PharmD
Employed as dispensing pharmacist, Minnesota Medical Solutions
Consultant, Iowa Cannabis Company
Maria Foy, PharmD
Employed part-time as a dispensing pharmacist, Restore PA, a PA cannabis dispensary, which is not a grower/processor licensee or cannabis product manufacturer
Joseph Morgan, MD, AACM
Consultant, Parea BioSciences (Applicant), Pennsylvania
Consultant, Intiva BioPharma, Inc
US Patent Pending related to Cannabinoids
Common shares, GW Pharma stock
The following speakers, faculty, and/ or planning committee members report that they, or a primary relative, have no actual or potential conflict of interest in relation to medical cannabis in the preceding 12 months.
Christine Roussel, PharmD, BCOP
David Johnson, PharmD, BCPS
Adam C. Lake, MD
Andrew Peterson, PharmD, PhD
Gail Groves Scott, MPH
Gail Groves Scott, MPH
Manager, Substance Use Disorders Institute
University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495